Author

S. H. Li

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. A. Adimora· 1 shared A. Kossenkov· 1 shared A. Landay· 1 shared A. Lucier· 1 shared A. Nelson· 1 shared B. D. Jamieson· 1 shared B. Macatangay· 1 shared C. K. Cunningham· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. A. Adimora

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintAug 9, 2023

Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection

L. B. Giron, Q. Liu, O. S. Adeniji…·M. A. Mohsen

This study identifies glycomic alterations in HIV-positive individuals that correlate with accelerated aging and comorbidities, suggesting potential biomarkers for early detection.

DOI 10.1101/2023.08.09.551369

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivSep 27, 2022

IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding

M. Bolton, C. P. Arevalo, T. Griesman…·S. E. Hensley

This study shows that IgG3 subclass antibodies neutralize antigenically drifted influenza and SARS-CoV-2 variants more effectively than other subclasses.

DOI 10.1073/pnas.2216521120

humanproteomics

𝕏 PostBluesky

ImmunologyThe Journal of Infectious DiseasesPeer-reviewedDec 28, 2021

Frequent development of broadly neutralizing antibodies in early life in a large cohort of HIV-infected children

G. G. Fouda, A. Lucier, Y. Fong…·S. R. Permar

This study finds that HIV-infected children aged 1-3 years develop broadly neutralizing antibodies with breadth comparable to adults, and overall higher than adults, suggesting early life immune advantages for HIV vaccine development.

DOI 10.1093/infdis/jiab629

humanbulk RNA-seq

𝕏 PostBluesky